PMCB vs RF
PharmaCyte Biotech Inc (PMCB) versus RF (RF) — a side-by-side from cached financials, not a winner call.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
RF (RF) common stock.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
RF does not have a complete income-statement cache yet.
PMCB currently screens at market cap $8.6M. RF currently screens at market cap $0.
Not investment advice. Open the PMCB and RF stock pages for the full models.
Not investment advice.